Hospital outpatient departments receive double reimbursement for identical drugs compared to physician offices

Data from the Employee Benefit Research Institute reveals a significant payment disparity in the commercial insurance market, with hospital outpatient departments receiving approximately twice the reimbursement for the same physician-administered medications compared to independent physician offices. This pricing gap has persisted largely unaddressed in the commercial marketplace despite growing awareness of the issue. Site-neutral payment policies could help standardize reimbursement rates across different care settings for identical drug administration.

Research conducted by the Employee Benefit Research Institute has documented a substantial gap in how insurance companies reimburse medication administration depending on the facility type. Hospital-based outpatient clinics receive payments roughly double those given to standalone medical practices for dispensing identical drugs to patients. This discrepancy has remained largely unresolved within commercial insurance markets, even as stakeholders have become increasingly aware of its existence.

Policymakers have proposed adopting site-neutral reimbursement frameworks as a potential remedy. Such approaches would establish uniform payment rates for the same pharmaceutical services regardless of whether they occur in a hospital setting or an independent office, potentially addressing longstanding inequities in the reimbursement structure.